By Reuters Staff
2 Min Read
April 15 (Reuters) - Australian shares fell on Thursday, as losses across the board and a mixed finish on Wall Street overnight weighed on the benchmark index.
The S&P/ASX 200 index fell 0.33% to 7,000.2 in early trade, after having closed above 7,000-mark on Wednesday for the first time since late-February last year.
Wall Street’s main indexes closed mixed overnight, with the Nasdaq Composite and S&P 500 seeing a fall. The Dow Jones Industrial Average rose on bumper bank earnings.
In other markets, Nikkei futures were up 0.32% and S&P 500 E-minis futures added 0.18%.
Australian tech shares fell 1.49%, led by losses in Nearmap Ltd, down 3.1%, and Xero Ltd that shed 2.83%.
Asian Open: Markets Take J&J Vaccine Halt Within Stride
Matt Simpson April 13, 2021 11:56 PM
Despite a risk-off start in futures markets, the Nasdaq 100 and DJI hit fresh highs despite the use of Johnson & Johnson (J&J) vaccine being halted in the US. Share:
Asian Futures:
Australia s ASX 200 futures are up 14 points (0.2%), the cash market is currently estimated to open at 6,990.90
Japan s Nikkei 225 futures are up 40 points (0.13%), the cash market is currently estimated to open at 29,791.61
Hong Kong s Hang Seng futures are up 95 points (0.33%), the cash market is currently estimated to open at 28,592.25
UK and Europe:
Germany s DAX futures are up 16 points (0.1%)
Australia shares rise as tech stocks track Wall Street higher reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Northern Star Resources Ltd (ASX: NST) will be on watch after the gold price tumbled lower overnight. According to CNBC, the spot gold price is down 0.7% to US$1,732.30 an ounce. The precious metal came under pressure after bond yields firmed up.
Webjet given buy rating
The
Webjet Limited(ASX: WEB) share price is still in the buy zone according to analysts at Goldman Sachs. In response to the completion of its convertible notes offering, the broker has retained its buy rating and $7.00 price target. This price target implies potential upside of almost 32% over the next 12 months for its shares.
Where to invest $1,000 right now
By Reuters Staff
2 Min Read
April 9 (Reuters) - Australian shares dipped on Friday, losing steam after a five-day winning streak, as setbacks to the nation’s COVID-19 vaccine rollout plans weighed on healthcare stocks, while weak iron ore prices pressured miners.
The S&P/ASX 200 index was down 0.2% at 6,985.4 points in early trade. The benchmark climbed more than 2% for the week and was poised for its third straight weekly gain.
Healthcare stocks shed more than 1% to hit a two-week low, with heavyweight CSL Ltd falling 1.3%.
The Australian government held a meeting with state and territory leaders following an abrupt policy shift that recommended people under 50 to take Pfizer’s COVID-19 vaccine rather than AstraZeneca’s shot.